Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04429347 · ClinicalTrials.gov registry record · Phase 2
Gabapentin and Tizanidine for Insomnia in Chronic Pain
A Phase 2 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT04429347 is a Phase 2 study that has completed, run by University of California, San Diego. The registered enrollment target is 9 participants.
The verdict
NCT04429347, a Phase 2 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a double-blind, placebo-controlled, randomized, crossover trial aimed at assessing the effect of gabapentin and tizanidine, two pain medications, on insomnia in chronic pain patients.
Interventions
- DRUG Placebo
- DRUG Gabapentin
- DRUG Tizanidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-07-29 |
| Est. Completion | 2024-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04429347
The ClinicalTrials.gov registry entry for NCT04429347 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04429347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04429347 about?
NCT04429347 is a clinical study titled "Gabapentin and Tizanidine for Insomnia in Chronic Pain". This is a double-blind, placebo-controlled, randomized, crossover trial aimed at assessing the effect of gabapentin and tizanidine, two pain medications, on insomnia in chronic pain patients.
What is the current status of trial NCT04429347?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2020-07-29. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT04429347?
The interventions under investigation include: Placebo (DRUG), Gabapentin (DRUG), Tizanidine (DRUG).
Who is sponsoring clinical trial NCT04429347?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.